Moreover, using integrated genomic analysis, it has been demonstrated that FLT3 and JAK-STAT activations are frequently found in T-cell immature/ETP ALL, suggesting a targeted therapy [14]. Here, FLT3 is linked to acute lymphoblastic leukemia.